Guoqiang Mao - Smyrna GA, US Steven W. Metzger - Westminster CO, US Michael J. Lochhead - Boulder CO, US David A. Goldberg - Boulder CO, US Charles H. Greef - Louisville CO, US David W. Grainger - Fort Collins CO, US
Assignee:
Accelr8 Technology Corporation - Denver CO
International Classification:
B05D 3/02
US Classification:
427384, 4273855, 4273881, 4273897, 4273935
Abstract:
Compositions and methods of preparing functional thin films or surface coatings with low non-specific binding are described. The thin films contain specified functional groups and non-specific binding repellant components. The thin films are either covalently bound to or passively adsorbed to various solid substrates. The specified functional group provides specified activity for the thin film modified solid surfaces and non-specific binding repellant components significantly reduce the non-specific binding to the thin film modified solid surfaces. Non-specific binding repellant components do not affect specified functional group's activity in the thin films. In these methods, specified functional groups are anchored to the solid substrates through a spacer. Surface coatings are also described having both non-specific protein binding properties combined with functional groups for specific binding activity thereby providing surface coating that specifically recognize target proteins but limit binding to non-specific protein.
Dr. Grainger graduated from the University of Kansas School of Medicine in 1981. He works in Wichita, KS and 1 other location and specializes in Reproductive Endocrinology. Dr. Grainger is affiliated with Wesley Medical Center.
ion to apparently connecting Mehra and Desai, Patel had prior connections with other authors of the NEJM paper and the preprint. David Grainger, co-author of the preprint, is a professor of biomedical engineering at the University of Utah and also works with Foldax. Grainger declined to comment.
Date: Jun 08, 2020
Category: More news
Source: Google
A mysterious company's coronavirus papers in top medical journals may be unraveling
viral Research on 3 April showed that it inhibits SARS-CoV-2 in a test tube. A 6 April preprint co-authored by Patel, Desai, and Mehra, along with David Grainger of the University of Utah, used Surgisphere data reportedly collected at 169 hospitals around the world between 1 January and 1 March. It
Joe Becerra, Marys Pinnell, Ted Nugent, Jamie Mcgugan, Tracy Lee, Kevin Bowers, Charlotte Murphy, Keith Marshall, Chris Cunningham, Charlie Gill, Tim Trelford